Top Story

Higher CV risk with acarbose than metformin in type 2 diabetes

March 27, 2015
In patients with type 2 diabetes, an initial regimen of acarbose therapy was associated with a moderately higher risk for cardiovascular disease compared with metformin therapy, according to recent findings.

In the nationwide cohort study, Lee-Ming Chuang, MD, PhD, of Nationwide Taiwan University Hospital, and colleagues evaluated data from the Taiwan National Health Insurance Database. The database includes information on outpatient visits, hospital admissions, prescriptions, disease and deaths for 99% of the population of Taiwan.

In the Journals

Updated diabetes care guidelines for PCPs stress importance of individualized treatment

March 23, 2015
Recent updates to the American Diabetes Association’s Standards of Medical Care in Diabetes place an emphasis on individualizing and tailoring care to each…
In the Journals

Diabetes prevalence lower in patients with familial hypercholesterolemia than unaffected relatives

March 11, 2015
Patients with familial hypercholesterolemia had a lower prevalence of type 2 diabetes compared with relatives without familial hypercholesterolemia, according to a…
Gabriela Vazquez-Benitez In the Journals

Diabetes, CVD increase rates of CV events

February 27, 2015
Among adults with diabetes, paying extra attention to traditional cardiovascular risk factors could reduce the rates of cardiovascular events and mortality, according to…
CME
Obesity Consults: Volume 2, Number 1

Obesity Consults: Volume 2, Number 1

This activity is supported by an educational grant from Vivus, Inc.

Obesity is suboptimally managed in clinical practice despite the availability of relevantguidelines and evidence-based…
More »
Meeting News Coverage Video
thumbnail for video 3857626096001

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
Healio CMHC2014 Ferdinand2 th Meeting News CoverageVideo

Keith C. Ferdinand, MD, highlights recent data on link between CVDs, diabetes drugs

October 30, 2014
BOSTON — At the Cardiometabolic Health Congress, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at Tulane University School of…
thumbnail for video 3857626096001 Meeting News CoverageVideo

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed primarily at diabetes or…
Keith C. Ferdinand Meeting News Coverage

Cardiometabolic Health Congress highlights latest research on CVD, diabetes, obesity

October 23, 2014
BOSTON — The latest innovative research in diabetes, hypertension, lipids, obesity and thrombosis was analyzed by experts at the…
In the Journals

Atherosclerosis risk increased among men with diabetes, low testosterone

October 17, 2014
A greater risk for developing atherosclerosis is found among middle-aged men with low testosterone and type 2 diabetes, according to recent study…
Meeting News Coverage

Biguanides, liraglutide reduced CVD risk in type 2 diabetes

September 24, 2014
Patients with type 2 diabetes treated with biguanides and liraglutide have a reduced risk for ischemic heart disease, heart failure and stroke…
Stijn Peeters Meeting News Coverage

Higher plasma levels linked to CV complications in type 1 diabetes

September 18, 2014
Cardiovascular complications are associated with higher plasma levels in patients with type 1 diabetes, according to a presenter at the 50th European…
In the Journals

Age, diabetes duration increases risk for macrovascular complications

September 12, 2014
For patients with type 2 diabetes, macrovascular events and death are associated with age or age at diagnosis and diabetes duration, according to…
Matthew J. Price, MD In the Journals

Clopidogrel response impaired among patients with diabetes, CAD

September 4, 2014
Patients with diabetes and CAD experienced an impaired response to platelet P2Y12 receptor antagonist clopidogrel compared with those without…
In the Journals

Insulin use, dialysis predicted poor wound healing after endovascular therapy

August 28, 2014
Patients undergoing endovascular therapy for critical limb ischemia were significantly more likely to have non-healing wounds if they used insulin…
James F. McKinsey In the JournalsPerspective

DEFINITIVE LE published: Directional atherectomy effective regardless of diabetes status

August 27, 2014
Patients with or without diabetes who underwent directional atherectomy for peripheral artery disease experienced similar rates of primary patency at…
More Headlines »
morganatic-roan
morganatic-roan